{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:55:11Z","timestamp":1793890511717,"version":"4.8.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-89874-5","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T22:06:56Z","timestamp":1739484416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["OM85 ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting Notch expression and modulating the IFN-\u03b3\/IL-4 ratio"],"prefix":"10.1038","volume":"15","author":[{"given":"Yaling","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuanyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianfeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinnong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"89874_CR1","first-page":"3291957","volume":"2023","author":"H He","year":"2023","unstructured":"He, H. et al. Medicine targeting epithelial-mesenchymal transition to treat airway remodeling and pulmonary fibrosis progression. Can. Respir. J. 2023, 3291957 (2023).","journal-title":"Can. Respir. J."},{"issue":"23","key":"89874_CR2","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1001\/jama.2019.7505","volume":"321","author":"T Bluth","year":"2019","unstructured":"Bluth, T. et al. Effect of intraoperative high positive end-expiratory pressure (PEEP) with recruitment maneuvers vs low PEEP on postoperative pulmonary complications in obese patients: a randomized clinical trial. JAMA 321(23), 2292\u20132305 (2019).","journal-title":"JAMA"},{"key":"89874_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2022.116343","volume":"459","author":"J Marzec","year":"2023","unstructured":"Marzec, J. & Nadadur, S. S. Inflammation resolution in environmental pulmonary health and morbidity. Toxicol. Appl. Pharmacol. 459, 116343 (2023).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"89874_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1164\/rccm.202312-2255ED","volume":"209","author":"F Darawshy","year":"2024","unstructured":"Darawshy, F., Molyneaux, P. L. & Segal, L. N. Looking beyond the lower airways for microbes affecting pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 209, 1054\u20131056 (2024).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"15","key":"89874_CR5","doi-asserted-by":"publisher","first-page":"11995","DOI":"10.3390\/ijms241511995","volume":"24","author":"CC Tseng","year":"2023","unstructured":"Tseng, C. C. et al. The role of macrophages in connective tissue disease-associated interstitial lung disease: Focusing on molecular mechanisms and potential treatment strategies. Int. J. Mol. Sci. 24(15), 11995 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"89874_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13020-023-00823-8","volume":"18","author":"S Pu","year":"2023","unstructured":"Pu, S. et al. Fermented cordyceps powder alleviates silica-induced pulmonary inflammation and fibrosis in rats by regulating the Th immune response. Chin. Med. 18(1), 131 (2023).","journal-title":"Chin. Med."},{"key":"89874_CR7","doi-asserted-by":"crossref","unstructured":"Qin, W., et al. A distinctive insight into inorganic sonosensitizers: Design principles and application domains. Small e2311228 (2024).","DOI":"10.1002\/smll.202311228"},{"issue":"7","key":"89874_CR8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1080\/14728222.2022.2114897","volume":"26","author":"P Spagnolo","year":"2022","unstructured":"Spagnolo, P. et al. The role of immune response in the pathogenesis of idiopathic pulmonary fibrosis: Far beyond the Th1\/Th2 imbalance. Expert Opin. Ther. Targets 26(7), 617\u2013631 (2022).","journal-title":"Expert Opin. Ther. Targets"},{"key":"89874_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2023.115647","volume":"267","author":"M Ding","year":"2023","unstructured":"Ding, M. et al. Silica-exposed macrophages-secreted exosomal miR125a-5p induces Th1\/Th2 and Treg\/Th17 cell imbalance and promotes fibroblast transdifferentiation. Ecotoxicol. Environ. Saf. 267, 115647 (2023).","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"3","key":"89874_CR10","first-page":"273","volume":"12","author":"XY Xing","year":"2020","unstructured":"Xing, X. Y. et al. Jinbei Oral Liquid ameliorates bleomycin-induced idiopathic pulmonary fibrosis in rats via reversion of Th1\/Th2 shift. Chin. Herb. Med. 12(3), 273\u2013280 (2020).","journal-title":"Chin. Herb. Med."},{"issue":"8","key":"89874_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/jcm7080201","volume":"7","author":"SL Barratt","year":"2018","unstructured":"Barratt, S. L. et al. Idiopathic pulmonary fibrosis (IPF): An overview. J. Clin. Med. 7(8), 201 (2018).","journal-title":"J. Clin. Med."},{"key":"89874_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2022.116070","volume":"449","author":"JM Marzec","year":"2022","unstructured":"Marzec, J. M. & Nadadur, S. S. Inflammation resolution in environmental pulmonary health and morbidity. Toxicol. Appl. Pharmacol. 449, 116070 (2022).","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"89874_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1165\/rcmb.2008-0260OC","volume":"42","author":"SE Evans","year":"2010","unstructured":"Evans, S. E. et al. Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi. Am. J. Respir. Cell. Mol. Biol. 42(1), 40\u201350 (2010).","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"issue":"4","key":"89874_CR14","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1007\/s10753-022-01653-w","volume":"45","author":"X Zhu","year":"2022","unstructured":"Zhu, X. et al. Pre-exposure to aerosolized polyvalent bacterial lysates protects against bleomycin-induced pulmonary fibrosis in mice. Inflammation 45(4), 1692\u20131699 (2022).","journal-title":"Inflammation"},{"key":"89874_CR15","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.jaci.2023.12.031","volume":"153","author":"N Go","year":"2024","unstructured":"Go, N. et al. A quantitative systems pharmacology workflow toward optimal design and biomarker stratification of atopic dermatitis clinical trials. J. Allergy Clin. Immunol. 153, 1330\u20131343 (2024).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"89874_CR16","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12890-023-02665-4","volume":"23","author":"JY Choi","year":"2023","unstructured":"Choi, J. Y. et al. Effect of Broncho-Vaxom (OM-85) on the frequency of chronic obstructive pulmonary disease (COPD) exacerbations. BMC Pulm. Med. 23(1), 378 (2023).","journal-title":"BMC Pulm. Med."},{"issue":"6","key":"89874_CR17","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.21037\/jtd-22-1469","volume":"15","author":"S Yao","year":"2023","unstructured":"Yao, S. et al. Bacterial lysate add-on therapy in adult and childhood asthma: A systematic review and meta-analysis. J. Thorac. Dis. 15(6), 3143\u20133157 (2023).","journal-title":"J. Thorac. Dis."},{"issue":"12","key":"89874_CR18","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1513\/AnnalsATS.202103-266OC","volume":"18","author":"SA Guler","year":"2021","unstructured":"Guler, S. A. et al. Azithromycin for the treatment of chronic cough in idiopathic pulmonary fibrosis: A randomized controlled crossover trial. Ann. Am. Thorac. Soc. 18(12), 2018\u20132026 (2021).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"89874_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev-pathol-042320-030240","volume":"17","author":"BJ Moss","year":"2022","unstructured":"Moss, B. J., Ryter, S. W. & Rosas, I. O. Pathogenic mechanisms underlying idiopathic pulmonary fibrosis. Annu. Rev. Pathol. 17, 515\u2013546 (2022).","journal-title":"Annu. Rev. Pathol."},{"issue":"8","key":"89874_CR20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1097\/00006454-199308000-00005","volume":"12","author":"JP Collet","year":"1993","unstructured":"Collet, J. P. et al. Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. The Epicr\u00e8che Research Group. Pediatr. Infect. Dis. J 12(8), 648\u2013652 (1993).","journal-title":"Pediatr. Infect. Dis. J"},{"issue":"10","key":"89874_CR21","first-page":"1269","volume":"239","author":"RS Nolen","year":"2011","unstructured":"Nolen, R. S. AVMA board approves Panel on Euthanasia report: Updated guidelines cover more species and methods. J. Am. Vet. Med. Assoc. 239(10), 1269 (2011).","journal-title":"J. Am. Vet. Med. Assoc."},{"issue":"1","key":"89874_CR22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1183\/09031936.01.00220001","volume":"18","author":"J Boe","year":"2001","unstructured":"Boe, J. et al. European respiratory society guidelines on the use of nebulizers. Eur. Respir. J. 18(1), 228\u2013242 (2001).","journal-title":"Eur. Respir. J."},{"issue":"3","key":"89874_CR23","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw, S., Nihal, M. & Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 22(3), 659\u2013661 (2008).","journal-title":"FASEB J."},{"issue":"3\u20134","key":"89874_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000195916","volume":"58","author":"J Paupe","year":"1991","unstructured":"Paupe, J. Immunotherapy with an oral bacterial extract (OM-85 BV) for upper respiratory infections. Respiration 58(3\u20134), 150\u2013154 (1991).","journal-title":"Respiration"},{"issue":"5","key":"89874_CR25","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1165\/rcmb.2017-0096ST","volume":"56","author":"RG Jenkins","year":"2017","unstructured":"Jenkins, R. G. et al. An official American thoracic society workshop report: Use of animal models for the preclinical assessment of potential therapies for pulmonary fibrosis. Am. J. Respir. Cell. Mol. Biol. 56(5), 667\u2013679 (2017).","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"issue":"3","key":"89874_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058658","volume":"8","author":"MA Seibold","year":"2013","unstructured":"Seibold, M. A. et al. The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. PLoS One 8(3), e58658 (2013).","journal-title":"PLoS One"},{"issue":"4","key":"89874_CR27","doi-asserted-by":"publisher","first-page":"L442","DOI":"10.1152\/ajplung.00026.2010","volume":"299","author":"AL Degryse","year":"2010","unstructured":"Degryse, A. L. et al. Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 299(4), L442\u2013L452 (2010).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"6","key":"89874_CR28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1165\/rcmb.2020-0542MA","volume":"64","author":"EF Redente","year":"2021","unstructured":"Redente, E. F. et al. Persistent, progressive pulmonary fibrosis and epithelial remodeling in mice. Am. J. Respir. Cell Mol. Biol. 64(6), 669\u2013676 (2021).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"2","key":"89874_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/01902148.2014.979516","volume":"41","author":"JD Williamson","year":"2015","unstructured":"Williamson, J. D., Sadofsky, L. R. & Hart, S. P. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis. Exp. Lung Res. 41(2), 57\u201373 (2015).","journal-title":"Exp. Lung Res."},{"issue":"1","key":"89874_CR30","doi-asserted-by":"publisher","first-page":"10404","DOI":"10.1038\/s41598-024-60864-3","volume":"14","author":"A Akenroye","year":"2024","unstructured":"Akenroye, A. et al. Ratio of plasma IL-13\/TNF- \u221d and CXCL10\/CCL17 predicts mepolizumab and omalizumab response in asthma better than eosinophil count or immunoglobulin E level. Sci. Rep. 14(1), 10404 (2024).","journal-title":"Sci. Rep."},{"issue":"6","key":"89874_CR31","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1128\/IAI.69.6.3719-3727.2001","volume":"69","author":"LM Bowman","year":"2001","unstructured":"Bowman, L. M. & Holt, P. G. Selective enhancement of systemic Th1 immunity in immunologically immature rats with an orally administered bacterial extract. Infect. Immun. 69(6), 3719\u20133727 (2001).","journal-title":"Infect. Immun."},{"issue":"2","key":"89874_CR32","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.21037\/jtd-24-28","volume":"16","author":"C Sun","year":"2024","unstructured":"Sun, C. et al. Improvement of idiopathic pulmonary fibrosis through a combination of Astragalus radix and Angelica sinensis radix via mammalian target of rapamycin signaling pathway-induced autophagy in rat. J. Thorac. Dis. 16(2), 1397\u20131411 (2024).","journal-title":"J. Thorac. Dis."},{"key":"89874_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fphar.2015.00215","volume":"6","author":"L Gao","year":"2015","unstructured":"Gao, L. et al. Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats. Front. Pharmacol. 6, 215 (2015).","journal-title":"Front. Pharmacol."},{"key":"89874_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2022.102005","volume":"81","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Knockdown of FBLN2 suppresses TGF-\u03b21-induced MRC-5 cell migration and fibrosis by downregulating VTN. Tissue Cell 81, 102005 (2023).","journal-title":"Tissue Cell"},{"issue":"1","key":"89874_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10209-021-00838-8","volume":"22","author":"S Singh","year":"2023","unstructured":"Singh, S., Jatana, N. & Goel, V. HELF (Haptic Encoded Language Framework): a digital script for deaf-blind and visually impaired. Univers. Access Inf. Soc. 22(1), 121\u2013131 (2023).","journal-title":"Univers. Access Inf. Soc."},{"key":"89874_CR36","doi-asserted-by":"crossref","unstructured":"Luan, H., et al. OM85-BV induced the productions of IL-1\u03b2, IL-6, and TNF-\u03b1 via TLR4- and TLR2-mediated ERK1\/2\/NF-\u03baB pathway in RAW264.7 cells. J. Interferon. Cytokine Res. 34(7), 526\u201336 (2014).","DOI":"10.1089\/jir.2013.0077"},{"issue":"11","key":"89874_CR37","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3390\/biomedicines9111544","volume":"9","author":"L Fang","year":"2021","unstructured":"Fang, L. et al. OM-85 Broncho-Vaxom(\u00ae), a bacterial lysate, reduces SARS-CoV-2 binding proteins on human bronchial epithelial cells. Biomedicines 9(11), 1544 (2021).","journal-title":"Biomedicines"},{"issue":"3","key":"89874_CR38","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/nar\/gkj465","volume":"34","author":"B Popova","year":"2006","unstructured":"Popova, B. et al. HelF, a putative RNA helicase acts as a nuclear suppressor of RNAi but not antisense mediated gene silencing. Nucleic Acids Res. 34(3), 773\u2013784 (2006).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"89874_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.psj.2024.103652","volume":"103","author":"T Wang","year":"2024","unstructured":"Wang, T. et al. Unmasking the dynamics of Mycoplasma gallisepticum: Deciphering HD11 macrophage polarization for innovative infection control strategies. Poult. Sci. 103(5), 103652 (2024).","journal-title":"Poult. Sci."},{"key":"89874_CR40","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s12013-024-01253-5","volume":"82","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. the role of macrophages in lung fibrosis and the signaling pathway. Cell Biochem. Biophys. 82, 479\u2013488 (2024).","journal-title":"Cell Biochem. Biophys."},{"key":"89874_CR41","doi-asserted-by":"publisher","first-page":"43844","DOI":"10.1038\/srep43844","volume":"7","author":"AT Dang","year":"2017","unstructured":"Dang, A. T. et al. OM-85 is an immunomodulator of interferon-\u03b2 production and inflammasome activity. Sci. Rep. 7, 43844 (2017).","journal-title":"Sci. Rep."},{"issue":"45","key":"89874_CR42","doi-asserted-by":"publisher","first-page":"eadi2167","DOI":"10.1126\/sciadv.adi2167","volume":"9","author":"R Guo","year":"2023","unstructured":"Guo, R. et al. Context-dependent regulation of Notch signaling in glial development and tumorigenesis. Sci. Adv. 9(45), eadi2167 (2023).","journal-title":"Sci. Adv."},{"key":"89874_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175959","volume":"956","author":"XC Wang","year":"2023","unstructured":"Wang, X. C. et al. New aspects of the epigenetic regulation of EMT related to pulmonary fibrosis. Eur. J. Pharmacol. 956, 175959 (2023).","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"89874_CR44","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1159\/000443115","volume":"38","author":"J Zhao","year":"2016","unstructured":"Zhao, J. et al. HuangQi decoction ameliorates renal fibrosis via TGF-\u03b2\/smad signaling pathway in vivo and in vitro. Cell Physiol. Biochem. 38(5), 1761\u20131774 (2016).","journal-title":"Cell Physiol. Biochem."},{"issue":"1","key":"89874_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/biomedicines11010163","volume":"11","author":"H Ling","year":"2023","unstructured":"Ling, H. et al. Role of ferroptosis in regulating the epithelial-mesenchymal transition in pulmonary fibrosis. Biomedicines 11(1), 163 (2023).","journal-title":"Biomedicines"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89874-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89874-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89874-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T22:09:07Z","timestamp":1739484547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89874-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["89874"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-89874-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"5 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5436"}}